Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.68M Sell
268,167
-7,729
-3% -$165K 0.18% 100
2026
Q1
$6.03M Buy
275,896
+173,841
+170% +$3.87M 0.41% 72
2025
Q4
$2.19M Sell
102,055
-60,131
-37% -$1.06M 0.17% 145
2025
Q3
$1.9M Buy
162,186
+46,755
+41% +$465K 0.16% 166
2025
Q2
$1.07M Buy
+115,431
New +$946K 0.29% 105

Other funds holding IMNM

Tema ETFs's IMNM Position: Q2 2026 in Review

Tema ETFs reduced its Immunome (IMNM) stake by 2.8% in Q2 2026, selling an estimated $165K and leaving 268,167 shares worth $5.68M. The position accounts for 0.18% of the portfolio, ranked #100.

Tema ETFs first reported a position in IMNM in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.03M in Q1 2026. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Tema ETFs held 268,167 shares of Immunome worth $5.68M as of Q2 2026.
  • Tema ETFs sold 7,729 Immunome shares in Q2 2026, an estimated $165K.
  • Immunome made up 0.18% of Tema ETFs's portfolio in Q2 2026, its #100 holding.
  • Tema ETFs first reported a position in Immunome in Q2 2025 and has held it in 5 quarters since.
  • Tema ETFs's Immunome position peaked at $6.03M in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.